These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22647134)

  • 1. Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.
    Al-Mahrous MM; Upton M
    Expert Opin Drug Discov; 2011 Feb; 6(2):155-70. PubMed ID: 22647134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipronged approach for engineering novel peptide analogues of existing lantibiotics.
    Escano J; Smith L
    Expert Opin Drug Discov; 2015; 10(8):857-70. PubMed ID: 26004576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing the success rate of lantibiotic drug discovery by Synthetic Biology.
    Montalbán-López M; Zhou L; Buivydas A; van Heel AJ; Kuipers OP
    Expert Opin Drug Discov; 2012 Aug; 7(8):695-709. PubMed ID: 22680308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential.
    Sandiford SK
    Expert Opin Drug Discov; 2014 Mar; 9(3):283-97. PubMed ID: 24410252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome database mining for the discovery of novel lantibiotics.
    Sandiford SK
    Expert Opin Drug Discov; 2017 May; 12(5):489-495. PubMed ID: 28306363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics synthesized by posttranslational modification.
    Hansen JN
    Annu Rev Microbiol; 1993; 47():535-64. PubMed ID: 8257108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel antibacterials.
    Miller JR; Waldrop GL
    Expert Opin Drug Discov; 2010 Feb; 5(2):145-54. PubMed ID: 22822914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans.
    van Heel AJ; Montalban-Lopez M; Kuipers OP
    Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):675-80. PubMed ID: 21521092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lantibiotics: diverse activities and unique modes of action.
    Asaduzzaman SM; Sonomoto K
    J Biosci Bioeng; 2009 May; 107(5):475-87. PubMed ID: 19393544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the isolation and characterization of antibacterial lantibiotics.
    Jabes D; Donadio S
    Methods Mol Biol; 2010; 618():31-45. PubMed ID: 20094856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fresh approaches to antidepressant drug discovery.
    Anacker C
    Expert Opin Drug Discov; 2014 Apr; 9(4):407-21. PubMed ID: 24588262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lantibiotics produced by lactic acid bacteria: structure, function and applications.
    Twomey D; Ross RP; Ryan M; Meaney B; Hill C
    Antonie Van Leeuwenhoek; 2002 Aug; 82(1-4):165-85. PubMed ID: 12369187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of lantibiotics from the lacticin 481 group is coming of age.
    Dufour A; Hindré T; Haras D; Le Pennec JP
    FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New generation of peptide antibiotics.
    Dubin A; Mak P; Dubin G; Rzychon M; Stec-Niemczyk J; Wladyka B; Maziarka K; Chmiel D
    Acta Biochim Pol; 2005; 52(3):633-8. PubMed ID: 16175238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.